Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy.
T-cell
biomimicry
cancer immunotherapy
dendritic cell
immunocyte membrane-coated nanoparticles
macrophage
natural killer
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
30 Dec 2020
30 Dec 2020
Historique:
received:
17
11
2020
revised:
15
12
2020
accepted:
17
12
2020
entrez:
5
1
2021
pubmed:
6
1
2021
medline:
6
1
2021
Statut:
epublish
Résumé
Despite the advances in surface bioconjugation of synthetic nanoparticles for targeted drug delivery, simple biological functionalization is still insufficient to replicate complex intercellular interactions naturally. Therefore, these foreign nanoparticles are inevitably exposed to the immune system, which results in phagocytosis by the reticuloendothelial system and thus, loss of their biological significance. Immunocyte membranes play a key role in intercellular interactions, and can protect foreign nanomaterials as a natural barrier. Therefore, biomimetic nanotechnology based on cell membranes has developed rapidly in recent years. This paper summarizes the development of immunocyte membrane-coated nanoparticles in the immunotherapy of tumors. We will introduce several immunocyte membrane-coated nanocarriers and review the challenges to their large-scale preparation and application.
Identifiants
pubmed: 33396603
pii: cancers13010077
doi: 10.3390/cancers13010077
pmc: PMC7794746
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Mater Chem B. 2020 Sep 21;8(35):8071-8083
pubmed: 32785386
Glycobiology. 2016 Jul;26(7):732-744
pubmed: 26873172
Adv Mater. 2019 May;31(18):e1900499
pubmed: 30907473
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13806-11
pubmed: 20643919
Nanotechnology. 2018 Apr 3;29(13):134004
pubmed: 29334363
J Nanobiotechnology. 2020 Jun 16;18(1):92
pubmed: 32546174
J Hematol Oncol. 2019 Dec 18;12(1):139
pubmed: 31852498
Trends Immunol. 2013 Apr;34(4):182-91
pubmed: 23414611
Nat Commun. 2020 Jul 3;11(1):3325
pubmed: 32620755
Nat Rev Immunol. 2020 Jan;20(1):7-24
pubmed: 31467405
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Mar;11(2):e1523
pubmed: 29701017
Future Oncol. 2019 Sep;15(26):3053-3069
pubmed: 31411057
ACS Nano. 2018 Dec 26;12(12):12096-12108
pubmed: 30444351
Mater Sci Eng C Mater Biol Appl. 2020 Oct;115:111097
pubmed: 32600701
Nat Rev Cancer. 2011 Oct 24;11(11):805-12
pubmed: 22020206
J Exp Med. 1998 Sep 7;188(5):953-60
pubmed: 9730896
Exp Dermatol. 2006 Nov;15(11):913-29
pubmed: 17002689
Sci Rep. 2020 Jun 15;10(1):9664
pubmed: 32541900
Semin Immunol. 2007 Feb;19(1):48-55
pubmed: 17276695
Small. 2015 Nov 4;11(41):5483-96
pubmed: 26331993
J Exp Med. 2002 Feb 4;195(3):F9-14
pubmed: 11828015
Nanomedicine (Lond). 2011 Apr;6(3):420
pubmed: 21695832
Nanomedicine (Lond). 2010 Jun;5(4):523-8
pubmed: 20528447
Nature. 1998 Mar 19;392(6673):245-52
pubmed: 9521319
PLoS Pathog. 2013 Sep;9(9):e1003538
pubmed: 24068918
J Immunol. 1986 Aug 15;137(4):1270-4
pubmed: 3525675
Int J Nanomedicine. 2020 Mar 19;15:1915-1928
pubmed: 32256068
Science. 2011 Jan 7;331(6013):44-9
pubmed: 21212348
J Transl Med. 2005 Mar 02;3(1):10
pubmed: 15740633
Annu Rev Immunol. 1994;12:337-65
pubmed: 8011285
Blood Adv. 2019 Jun 11;3(11):1681-1694
pubmed: 31167820
Biomaterials. 2018 Apr;160:124-137
pubmed: 29407341
J Cell Biol. 2002 Jun 24;157(7):1233-45
pubmed: 12082081
Pathol Biol. 1968 Nov;16(21):973-7
pubmed: 4891840
IUBMB Life. 2011 Aug;63(8):621-31
pubmed: 21766411
J Leukoc Biol. 1986 Jul;40(1):97-111
pubmed: 3011937
Nano Lett. 2018 Mar 14;18(3):1908-1915
pubmed: 29473753
J Neuropathol Exp Neurol. 2004 May;63(5):474-83
pubmed: 15198126
Adv Sci (Weinh). 2019 Jun 11;6(15):1900251
pubmed: 31406665
Biomater Sci. 2020 Jan 21;8(2):552-568
pubmed: 31769765
Clin Med Insights Pathol. 2016 Sep 14;9(Suppl 1):1-8
pubmed: 27660518
Immunol Rev. 2012 Jul;248(1):228-39
pubmed: 22725965
Nat Commun. 2018 Oct 31;9(1):4548
pubmed: 30382085
Biomed Res Int. 2015;2015:320941
pubmed: 25866775
Adv Healthc Mater. 2019 Feb;8(4):e1801091
pubmed: 30565895
Crit Rev Ther Drug Carrier Syst. 2016;33(6):489-567
pubmed: 27992308
Brain Res. 2011 Jan 7;1367:62-76
pubmed: 20875807
Mater Sci Eng C Mater Biol Appl. 2020 Jan;106:110298
pubmed: 31753336
J Leukoc Biol. 1996 Sep;60(3):296-309
pubmed: 8830785
Expert Opin Emerg Drugs. 2020 Dec;25(4):445-453
pubmed: 33040627
Int Rev Immunol. 2008;27(3):93-110
pubmed: 18437601
Front Immunol. 2019 Apr 09;10:719
pubmed: 31024551
Expert Opin Drug Deliv. 2013 Jan;10(1):47-58
pubmed: 23078091
ACS Appl Mater Interfaces. 2018 Sep 19;10(37):31124-31135
pubmed: 30141614
Curr Opin Immunol. 1992 Oct;4(5):608-12
pubmed: 1418727
Br J Cancer. 2020 Sep 15;:
pubmed: 32929195
Rheumatology (Oxford). 2010 Jul;49(7):1215-28
pubmed: 20194223
Cell. 1987 Jan 30;48(2):231-40
pubmed: 3026637
Int J Cancer. 1975 Aug 15;16(2):216-29
pubmed: 50294
Nat Rev Immunol. 2011 Oct 25;11(11):788-98
pubmed: 22025056
Br Med Bull. 1968 May;24(2):101-6
pubmed: 5649925
Cell. 2002 Dec 27;111(7):927-30
pubmed: 12507420
Nat Rev Cancer. 2020 Jan;20(1):26-41
pubmed: 31601988
Bioconjug Chem. 2017 Jan 18;28(1):23-32
pubmed: 27798829
Drug Discov Today. 2018 Apr;23(4):891-899
pubmed: 29426004
Cell Immunol. 1991 Oct 1;137(1):164-74
pubmed: 1832087
Nat Commun. 2020 Sep 30;11(1):4909
pubmed: 32999291
Nanomedicine (Lond). 2020 Mar;15(6):625-641
pubmed: 32098564
ACS Nano. 2020 Sep 22;14(9):11452-11462
pubmed: 32820907
Nature. 2015 Oct 1;526(7571):118-21
pubmed: 26374997
Curr Opin Hematol. 2001 Mar;8(2):80-4
pubmed: 11224681
Adv Healthc Mater. 2015 Aug 5;4(11):1645-52
pubmed: 25960053
Front Immunol. 2013 Jan 09;3:408
pubmed: 23316196
Nat Rev Immunol. 2018 Nov;18(11):671-688
pubmed: 30209347
Expert Opin Drug Deliv. 2010 Apr;7(4):403-27
pubmed: 20192900
Pharmaceutics. 2020 May 09;12(5):
pubmed: 32397513
J Biomed Mater Res A. 2017 Feb;105(2):521-530
pubmed: 27718539
Nat Rev Cancer. 2002 Nov;2(11):850-61
pubmed: 12415255
Oncoimmunology. 2013 Dec 1;2(12):e26663
pubmed: 24498552
Curr Opin Immunol. 2006 Feb;18(1):49-53
pubmed: 16338128
Methods Mol Biol. 2020;2097:3-44
pubmed: 31776916
Acta Pharmacol Sin. 2017 Jun;38(6):754-763
pubmed: 28392567
Nature. 1987 Jul 16-22;328(6127):267-70
pubmed: 3496540
Nature. 2011 Dec 21;480(7378):480-9
pubmed: 22193102
J Drug Deliv. 2013;2013:869718
pubmed: 24228179
Cancer Immunol Res. 2015 Apr;3(4):305-12
pubmed: 25847967
J Theor Biol. 1967 Jun;15(3):307-24
pubmed: 5339810
Front Bioeng Biotechnol. 2020 Aug 11;8:943
pubmed: 32850765
Biomaterials. 2019 Aug;211:48-56
pubmed: 31085358
J Immunol. 1987 Feb 1;138(3):957-62
pubmed: 3492537
Front Oncol. 2020 Aug 05;10:1362
pubmed: 32850436
Theranostics. 2020 Jan 1;10(3):1281-1295
pubmed: 31938065
Front Immunol. 2020 May 12;11:812
pubmed: 32477340
Annu Rev Immunol. 2005;23:901-44
pubmed: 15771589
Ann Biomed Eng. 2020 Jan;48(1):236-246
pubmed: 31410713
Annu Rev Immunol. 2001;19:197-223
pubmed: 11244035
Eur J Immunol. 1999 Nov;29(11):3588-95
pubmed: 10556813
Biochemistry. 2020 Jun 2;:
pubmed: 32452667
Cell Immunol. 1989 Aug;122(1):1-10
pubmed: 2502315
Adv Exp Med Biol. 1992;326:239-45
pubmed: 1295313
Cancer Res. 2014 Jul 1;74(13):3429-40
pubmed: 24780758
Bone Res. 2017 Oct 17;5:17019
pubmed: 29263936
Biomacromolecules. 2015 Apr 13;16(4):1311-21
pubmed: 25794196
J Hematol Oncol. 2020 Aug 3;13(1):107
pubmed: 32746880
J Neurosurg. 1998 Oct;89(4):559-67
pubmed: 9761049
J Hematol Oncol. 2019 Sep 6;12(1):93
pubmed: 31492199
Mol Cell Biol. 2014 Mar;34(5):888-99
pubmed: 24366546
Acta Pharm Sin B. 2018 Jan;8(1):14-22
pubmed: 29872619
Biomed Res Int. 2015;2015:178698
pubmed: 26161387
Front Immunol. 2019 Oct 29;10:2393
pubmed: 31736936
Eur J Immunol. 1975 Feb;5(2):112-7
pubmed: 1234049
Small. 2019 Jan;15(1):e1804105
pubmed: 30457701
ACS Omega. 2020 Jan 13;5(3):1572-1580
pubmed: 32010831
J Exp Med. 1996 Mar 1;183(3):725-9
pubmed: 8642276
Mt Sinai J Med. 2001 May;68(3):160-6
pubmed: 11373688
ACS Nano. 2016 Aug 23;10(8):7738-48
pubmed: 27454827